Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cancer Survival Analysis01:21

Cancer Survival Analysis

321
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
321
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Real-World Data on the Use of Nivolumab Monotherapy in the Treatment of Advanced Renal Cell Carcinoma After Prior Therapy: Final Results from the Non-Interventional NORA Study.

Cancers·2026
Same author

[New developments in endocrinology/diabetology].

Innere Medizin (Heidelberg, Germany)·2026
Same author

Erdafitinib in Patients With Advanced Solid Tumors With <i>FGFR</i> Alterations (RAGNAR): Results of Tumor-Specific Analyses and Secondary Cohorts.

JCO precision oncology·2026
Same author

Prospective randomized analysis of operating time and safety of laparoscopic pyeloplasty with or without TriSect rapide® in adult patients with ureteropelvic junction obstruction.

BMC urology·2026
Same author

Confirmation of Prostate-specific Antigen (PSA) Values Improves Prostate Cancer Screening in Early Middle-Aged Men - Data from the PROBASE Trial.

European urology·2026
Same author

Large language models enable prognostic stratification of cancer patients using real-world clinical notes.

PLOS digital health·2026

相关实验视频

Updated: May 30, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K

解码泛癌治疗结果使用多式联络现实世界数据和可解释的人工智能.

Julius Keyl1,2, Philipp Keyl3,4, Grégoire Montavon4,5,6

  • 1Institute for Artificial Intelligence in Medicine, University Hospital Essen (AöR), Essen, Germany.

Nature cancer
|January 30, 2025
PubMed
概括

可解释的人工智能 (xAI) 从多式联络数据中识别关键标记和相互作用,以改善癌症患者的预测结果. 这种方法增强了临床决策,并支持个性化,数据驱动的癌症护理.

更多相关视频

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.4K
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

8.9K

相关实验视频

Last Updated: May 30, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.4K
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

8.9K

科学领域:

  • 在瘤学瘤学.
  • 人工智能的人工智能
  • 生物信息学是一种生物信息学.

背景情况:

  • 精确瘤学目前依赖于有限的临床变量和专家知识来做出决策.
  • 需要先进的方法来整合各种患者数据,以改善癌症护理.

研究的目的:

  • 引入AI衍生 (AID) 标记,使用可解释的人工智能 (xAI) 进行临床决策支持.
  • 通过分析多式联络现实世界数据,并识别关键预后标志物及其相互作用来解码患者的结果.

主要方法:

  • 利用xAI分析了来自38种固体癌症类型的15726名患者的数据.
  • 整合了350个标记物,包括临床记录,图像衍生的身体组成和突变瘤概况.
  • 从电子健康记录中对3,288名肺癌患者的独立队列中验证了该方法.

主要成果:

  • 确定了114个关键标记,这些标记对神经网络的90%决策过程有所贡献.
  • 发现了这些标志物之间的1373个预后相互作用.
  • 在验证队列中证明了模型的预测能力.

结论:

  • xAI可以有效地解码复杂的患者数据,以识别显著的预后标志物和相互作用.
  • 这种方法有可能改变瘤学中的临床变量评估.
  • 通过增强的决策支持,使得癌症护理更加个性化和数据驱动.